These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 19340656

  • 1. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.
    Naumnik W, Chyczewska E, Ossolinska M.
    Cancer Invest; 2009 Aug; 27(7):741-6. PubMed ID: 19340656
    [Abstract] [Full Text] [Related]

  • 2. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK, Blann A, Beevers DG, Lip GY.
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [Abstract] [Full Text] [Related]

  • 3. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY.
    J Am Coll Cardiol; 2004 Feb 04; 43(3):423-8. PubMed ID: 15013125
    [Abstract] [Full Text] [Related]

  • 4. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer.
    Park JH, Choi H, Kim YB, Kim YS, Sheen SS, Choi JH, Lee HL, Lee KS, Chung WY, Lee S, Park KJ, Hwang SC, Lee KB, Park KJ.
    Lung Cancer; 2009 Dec 04; 66(3):359-64. PubMed ID: 19339077
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D, Soydinç HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E.
    Lung Cancer; 2008 Feb 04; 59(2):240-5. PubMed ID: 17875341
    [Abstract] [Full Text] [Related]

  • 6. Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers.
    Niedźwiecki S, Stepień T, Kopeć K, Kuzdak K, Komorowski J, Krupiński R, Stepień H.
    Cytokine; 2006 Dec 04; 36(5-6):291-5. PubMed ID: 17374490
    [Abstract] [Full Text] [Related]

  • 7. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW, Lip GY, Blann AD.
    Circulation; 2004 Oct 19; 110(16):2355-60. PubMed ID: 15302795
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.
    Cancer Invest; 2006 Oct 19; 24(6):576-80. PubMed ID: 16982461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma concentrations of angiopoietin-1, angiopoietin-2 and Tie-2 in colon cancer.
    Engin H, Üstündağ Y, Tekin İÖ, Gökmen A, Ertop Ş, İlikhan SU.
    Eur Cytokine Netw; 2012 Jun 19; 23(2):68-71. PubMed ID: 22728324
    [Abstract] [Full Text] [Related]

  • 12. Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study.
    Naumnik W, Naumnik B, Niewiarowska K, Ossolinska M, Chyczewska E.
    Adv Exp Med Biol; 2013 Jun 19; 788():341-8. PubMed ID: 23835996
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.
    De Vita F, Orditura M, Auriemma A, Infusino S, Roscigno A, Catalano G.
    Oncol Rep; 1998 Jun 19; 5(3):649-52. PubMed ID: 9538169
    [Abstract] [Full Text] [Related]

  • 14. [Assessment of the selected, late phase of angiogenesis factors' concentration in colorectal cancer patients].
    Wieloch M, Swiatkowska M, Libiszewski M, Hedayati M, Drozda R, Kołomecki K.
    Pol Merkur Lekarski; 2009 Dec 19; 27(162):466-9. PubMed ID: 20120708
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients.
    Seker MM, Sancaktar E, Acibucu DO, Filiz AK, Deveci K, Bahceci A, Kacan T, Babacan N, Yuce S.
    Eur Rev Med Pharmacol Sci; 2013 Nov 19; 17(21):2929-32. PubMed ID: 24254563
    [Abstract] [Full Text] [Related]

  • 16. Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
    Anargyrou K, Terpos E, Vassilakopoulos TP, Pouli A, Sachanas S, Tzenou T, Masouridis S, Christoulas D, Angelopoulou MK, Dimitriadou EM, Kalpadakis C, Tsionos K, Panayiotidis P, Dimopoulos MA, Pangalis GA, Kyrtsonis MC, Greek Myeloma Study Group.
    Haematologica; 2008 Mar 19; 93(3):451-4. PubMed ID: 18287135
    [Abstract] [Full Text] [Related]

  • 17. Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies.
    Quartarone E, Alonci A, Allegra A, Bellomo G, Calabrò L, D'Angelo A, Del Fabro V, Grasso A, Cincotta M, Musolino C.
    Eur J Haematol; 2006 Dec 19; 77(6):480-5. PubMed ID: 16978237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.
    Figueroa-Vega N, Díaz A, Adrados M, Alvarez-Escolá C, Paniagua A, Aragonés J, Martín-Pérez E, Leskela S, Moreno-Otero R, González-Amaro R, Marazuela M.
    Endocr Relat Cancer; 2010 Dec 19; 17(4):897-908. PubMed ID: 20696814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.